Guiding Practices for Patient-Centered Value Assessment
In 2016, NP developed Guiding Practices for Patient-Centered Value Assessment that included 28 specific elements, which are broken out into six key aspects of value assessments: the assessment process, methodology, benefits, costs, evidence, and dissemination and utilization. Guiding practices for budget impact assessment are outlined separately as budget impact is not a measure of value.
In January 2024, The National Pharmaceutical Council (NPC) updated its Guiding Practices for Patient-Centered Value Assessment. This update of NPC's guiding practices for US value assessment will help inform the growing importance of this tool to support pricing pharmaceuticals based on the value they provide to patients and society as a whole. NPC first published guiding practices for value assessment in 2016. That was a time when multiple organizations had created unique value assessment frameworks, each for different purposes.
Since then, the US experience with value assessment has changed substantially, with activities increasingly focused on the value of pharmaceuticals. At the time of publication, the Institute for Clinical and Economic Review (ICER) now issues 6-8 assessments per year, and the Centers for Medicare and Medicaid Services' Drug Price Negotiation Program under the Inflation Reduction Act appears to some observers as a form of value assessment, even though (as of this writing) neither the CMS guidance nor statements from agency officials explain whether the government's goal is to lower drug prices, reduce patient out-of-pocket costs, or get more value for the government's money. In addition, the research methods supporting value assessment - particularly around the inclusion of the patient voice in these evaluations - have continued to evolve.
These have all factored into the 2024 update of NPC's guiding practices for US value assessment to help inform the growing importance of this tool to support pricing pharmaceuticals based on the value they provide to patients and society as a whole.
Access the updated Guiding Practices for Patient-Centered Value Assessment.
...........................................................................
March 2016
Download the 2016 Guiding Practices | Download the 2016 infographic